# OnCo record paper-alfonso-racotumomab-maintenance-nsclc-ccr-2014 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-alfonso-racotumomab-maintenance-nsclc-ccr-2014/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-alfonso-racotumomab-maintenance-nsclc-ccr-2014" ;
  schema:name "Racotumomab-alum vaccine as switch maintenance in advanced non-small cell lung cancer: a randomised placebo-controlled trial"@en ;
  schema:description "In 176 patients with advanced lung cancer whose disease was controlled by chemotherapy, the Cuban anti-idiotype vaccine racotumomab lengthened median survival from 6.8 to 8.2 months compared with placebo."@en ;
  schema:url <https://onco.cc/key-papers/paper-alfonso-racotumomab-maintenance-nsclc-ccr-2014/> ;
  schema:dateModified "2026-11-11"^^xsd:date ;
  schema:citation <https://doi.org/10.1158/1078-0432.CCR-13-1674>, <https://pubmed.ncbi.nlm.nih.gov/24788102/> ;
  schema:sameAs <https://doi.org/10.1158/1078-0432.CCR-13-1674> ;
  schema:datePublished "2014"^^xsd:gYear ;
  schema:author "Alfonso S, Valdés-Zayas A, Santiesteban ER, et al." ;
  onco:cancers <https://onco.cc/cancers/nsclc/> ;
  onco:drugs <https://onco.cc/drugs/racotumomab/> ;
  onco:companies <https://onco.cc/companies/cimab/> ;
  onco:institutions <https://onco.cc/institutions/inor-cuba/>, <https://onco.cc/institutions/cencec-cuba/> .
